Clinical trials recruiting for NSCLC, Stage I
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BIO 300 | 1 |
| Osimertinib | 1 |
| Pembrolizumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Jersey | 2 |
| Florida | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Iowa | 1 |
| Minnesota | 1 |
| Nebraska | 1 |
| New York | 1 |
| Ohio | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
- A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
- Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
- Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
Related conditions
Trials recruiting for NSCLC, Stage I often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for NSCLC, Stage I trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.